Año: 1999
Journal Impact Factor (JIF): 1.4380
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
PLANT SCIENCES | SCIE | 33/136 | Q1 | T1 | D3 |
PHARMACOLOGY & PHARMACY | SCIE | 69/175 | Q2 | T2 | D4 |
CHEMISTRY, MEDICINAL | SCIE | 14/30 | Q2 | T2 | D5 |
Año: 2017
Journal Citation Indicator (JCI): 0,870
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CHEMISTRY, MEDICINAL | 27/70 | Q2 | T2 | D4 | 62,14 |
INTEGRATIVE & COMPLEMENTARY MEDICINE | 12/37 | Q2 | T1 | D4 | 68,92 |
PHARMACOLOGY & PHARMACY | 111/336 | Q2 | T1 | D4 | 67,11 |
PLANT SCIENCES | 71/239 | Q2 | T1 | D3 | 70,50 |
Año:
2011
CiteScore:
3,500
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Complementary and Alternative Medicine | 6/78 | Q1 | T1 | D1 |
Pharmaceutical Science | 31/169 | Q1 | T1 | D2 |
Drug Discovery | 47/140 | Q2 | T2 | D4 |
Organic Chemistry | 55/152 | Q2 | T2 | D4 |
Pharmacology | 121/304 | Q2 | T2 | D4 |
Analytical Chemistry | 35/86 | Q2 | T2 | D5 |
Molecular Medicine | 77/145 | Q3 | T2 | D6 |
SJR año:
1999
Factor de Impacto:
0,912
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Complementary and Alternative Medicine | 2/38 | Q1 | T1 | D1 |
Pharmaceutical Science | 9/108 | Q1 | T1 | D1 |
Pharmacology | 40/273 | Q1 | T1 | D2 |
Drug Discovery | 16/73 | Q1 | T1 | D3 |
Organic Chemistry | 31/131 | Q1 | T1 | D3 |
Analytical Chemistry | 28/82 | Q2 | T2 | D4 |
Molecular Medicine | 32/71 | Q2 | T2 | D5 |
# | Autor | Afiliación |
---|---|---|
1 | de la Puerta, R | Universidad de Sevilla; King's College London (United Kingdom) |
2 | Forder, RA | AstraZeneca (United Kingdom) |
3 | King's College London (United Kingdom) |